An Independent Magazine for the Second Act  ·  After Forty Feel
Body · Practical

Magnesium at 50 — which form you take matters more than you think.

Half of adults over 50 don't get enough magnesium from food. But the form you supplement with determines whether it reaches the tissues you're actually trying to support — and the differences between glycinate, threonate, malate, and oxide are not trivial.

The deficiency problem nobody is talking about

Magnesium is involved in over 300 enzymatic reactions in the human body — ATP production, DNA repair, muscle contraction, nerve signalling, insulin sensitivity, and the regulation of calcium channels that influence both heart rhythm and neuronal excitability. It's one of the most metabolically central minerals in human physiology, and a substantial portion of the midlife population doesn't have enough of it.

The National Health and Nutrition Examination Survey (NHANES) data, analysed by Rosanoff, Weaver, and Rude in Nutrition Reviews (2012), found that approximately 48% of Americans consumed less magnesium than the estimated average requirement — and this figure was higher in older adults. The RDA for adults over 50 is 420 mg/day for men and 320 mg/day for women, but dietary surveys consistently show average intakes of 250–320 mg/day across all adults. The gap is real.

There's also an absorption problem that worsens with age. Magnesium absorption occurs primarily in the small intestine via both active transport and passive diffusion. Active transport efficiency declines with age, and conditions common in the over-50 population — proton pump inhibitor use, type 2 diabetes, reduced stomach acid, and chronic alcohol intake — all impair it further. A 2018 analysis in Nutrients (Veronese et al.) found that older adults with lower dietary magnesium intake had significantly higher rates of frailty, inflammation (measured by CRP), and muscle weakness, even after adjustment for other nutrients.

Why serum magnesium is a terrible test for deficiency

If you ask your GP to check your magnesium, they'll likely order serum magnesium — a test that measures the tiny 1% of total body magnesium that circulates in the blood. The body defends serum magnesium aggressively through renal reabsorption; by the time serum magnesium drops below normal, tissue-level depletion can already be severe. Studies using more sensitive assays — 24-hour urinary magnesium, or magnesium loading tests — consistently find intracellular deficiency in people with normal serum levels.

This means that if your serum magnesium comes back "normal," it tells you almost nothing about whether your muscles, brain, or cardiovascular system are adequately supplied. The more useful heuristic is dietary intake combined with symptoms: muscle cramps and twitches at rest, difficulty initiating sleep or staying asleep, increased migraine frequency, and heightened stress reactivity are all associated with low magnesium intake in observational data.

The form question — what each type actually does

Magnesium supplements differ in two key ways: elemental magnesium content (how much actual magnesium per dose) and the chelating compound, which affects where and how well it's absorbed, and whether it has effects beyond magnesium repletion.

Magnesium oxide is the form used in most cheap multivitamins and many antacids. It has a high elemental magnesium content (60% by weight), which makes the numbers look impressive on labels. But its bioavailability is poor — an RCT by Firoz and Graber published in Magnesium Research (2001) found bioavailability of roughly 4% for magnesium oxide compared to 10% for magnesium chloride. You're essentially paying for magnesium that passes through. The primary legitimate use for oxide is its laxative effect — useful if you're constipated, unhelpful if you're trying to correct a systemic deficiency.

Magnesium glycinate (magnesium bound to the amino acid glycine) is the most widely evidence-supported form for general supplementation. Glycine enhances intestinal absorption through its own transporter, and glycine itself has calming, sleep-facilitating properties — a 2012 study in Sleep and Biological Rhythms (Bannai et al.) found that 3g of glycine at bedtime improved subjective sleep quality and reduced daytime sleepiness. The magnesium-glycine combination is gentle on the gut, has good bioavailability relative to inorganic forms, and the glycine synergy makes it particularly useful for people targeting sleep and stress.

The absorption hierarchy you should know In head-to-head comparisons, organic magnesium compounds (glycinate, malate, citrate, threonate) consistently outperform inorganic forms (oxide, carbonate). A 2003 study in Magnesium Research by Walker et al. found magnesium citrate produced significantly higher serum magnesium concentrations than magnesium oxide over 60 days. Glycinate and malate appear to have comparable systemic absorption to citrate, with better GI tolerability at higher doses.

Magnesium threonate (MgT) is the form most explicitly targeted at brain function. The threonate ion was identified in a 2010 MIT study by Slutsky et al. published in Neuron as capable of crossing the blood-brain barrier more efficiently than other magnesium compounds, raising cerebrospinal fluid magnesium levels in rodent models. The same study showed improvements in synaptic density and cognitive performance in aging rats. Human data has since emerged: a randomised trial by Liu et al. in the Journal of Alzheimer's Disease (2016) found that MgT supplementation over 12 weeks improved cognitive measures in older adults with mild cognitive impairment. The effect sizes were modest — not a dramatic cognitive overhaul — but the direction is consistent with the mechanistic story. The limitation is cost: MgT is substantially more expensive than glycinate, and the human trial evidence base is still thin compared to the rodent literature.

Magnesium malate (bound to malic acid) has particular relevance for energy metabolism, because malate is an intermediate in the citric acid cycle — the mitochondrial pathway that generates ATP. Small trials in fibromyalgia patients have shown subjective improvements in fatigue and pain, though the fibromyalgia evidence base has significant methodological limitations. What malate does have going for it is good GI tolerability, reasonable bioavailability, and a theoretical fit for people whose primary symptom is fatigue and muscle pain rather than sleep disruption or cognitive concerns.

Matching the form to what you're actually trying to address

The practical decision tree looks like this: if your primary concern is sleep quality and stress resilience, glycinate is the most established and cost-effective choice. If cognitive function and brain aging are your primary target, threonate is worth the premium but go in with realistic expectations on effect size — you're not going to feel dramatically sharper in week two. If fatigue and muscle recovery are the primary complaint and you've already ruled out iron deficiency and thyroid dysfunction, malate offers a plausible mechanistic fit. If you're constipated and want something to move things along, oxide is fine. If you're trying to use oxide for anything else, you're mostly supplementing your toilet.

Dosing: most research uses 200–400 mg elemental magnesium daily. Glycinate supplements typically contain 100–200 mg elemental magnesium per capsule — so two capsules at night is a reasonable starting dose. Titrate up if symptoms persist, and if you get loose stools, reduce the dose. The laxative threshold varies considerably between people, and organic forms are generally much gentler than inorganic ones at equivalent elemental doses.

One interaction worth knowing: magnesium competes with calcium for intestinal absorption. Taking them together in high doses can reduce the uptake of both. If you're taking calcium supplementation as well, spacing magnesium to evening and calcium to morning is a simple practical step.

Sources:
Rosanoff A, Weaver CM, Rude RK. "Suboptimal magnesium status in the United States." Nutrition Reviews 2012;70(3):153–164. doi:10.1111/j.1753-4887.2011.00465.x
Veronese N et al. "Dietary magnesium intake and fracture risk: data from a large prospective study." Br J Nutr 2017;117(11):1570–1576.
Firoz M, Graber M. "Bioavailability of US commercial magnesium preparations." Magnes Res 2001;14(4):257–262.
Bannai M, Kawai N. "New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep." J Pharmacol Sci 2012;118(2):145–148. doi:10.1254/jphs.11r04fm
Slutsky I et al. "Enhancement of learning and memory by elevating brain magnesium." Neuron 2010;65(2):165–177. doi:10.1016/j.neuron.2009.12.026
Liu G et al. "Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults." J Alzheimers Dis 2016;49(4):971–990. doi:10.3233/JAD-150538
Walker AF et al. "Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study." Magnes Res 2003;16(3):183–191.

What's your hormone age?

12 questions. 90 seconds. Free result with the research links.

Take the calculator →